At a glance
- Originator Nippon Organon
- Developer Nippon Organon; Nonindustrial source
- Class Antiulcers; Piperazines; Small molecules
- Mechanism of Action Opioid receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Peptic ulcer
Most Recent Events
- 08 Dec 1994 Discontinued-II for Peptic ulcer in Japan (PO)